Skyhawk Therapeutics Announces Final Fifteen-Month Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease Patients
The fifteen-month dataset represents the final analysis from the Phase 1/2 study At the Month 15 primary timepoint, SKY-0515-treated patients showed a +1.59-point difference in Composite Unified Huntington's Disease Rating Scale (cUHDRS) change from...
51Talk Online Education Group Announces Second Quarter 2026 Results
SINGAPORE, Sept. 15, 2026 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the second...
AXLBIT ASIA Announces September Launch of AXLBOX in Malaysia, Bringing Quality-Assured Enterprise Software and Practical AI to Southeast Asia
Platform introduces cloud-based industrial AI, secure file transfer, IT asset management and cyber protection as first-phase services KUALA LUMPUR, Malaysia and SINGAPORE, Sept. 15, 2026 /PRNewswire/ -- AXLBIT ASIA SDN. BHD. ("AXLBIT ASIA")...
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.96 Million Tokens, and Total Crypto and Total Cash Holdings of $15.8 Billion
Bitmine owns 4.9% of the total ETH coin supply of 122.0 million Bitmine is 98% of the way to the 'Alchemy of 5%' in just 15 months ETH is the best performing macro asset in Q3 of 2026 to date, outperforming the S&P 500 by 5,866bp Tom Lee to...
Jianpu Technology Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend
BEIJING, Sept. 14, 2026 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (OTCQB: AIJTY), a leading open financial technology platform in China, today announced that FINRA has set October 20, 2026 as the ex-dividend date for the...
Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development
NEW YORK and SUZHOU, China, Sept. 14, 2026 /PRNewswire/ -- On September 14, 2026 (China Standard Time, UTC+8), Accro Bioscience announced that AC-101 tablets have been included in the Rare Diseases Innovative Drug Development Encouragement Pilot...
Auria Announces Partnership and Contract with Mitsubishi Electric to Advance Next-Generation SATCOM Mission and Resource Management
COLORADO SPRINGS, Colo., Sept. 14, 2026 /PRNewswire/ -- Auria, a leading provider of advanced space, missile, and cyber solutions, today announced a partnership and contract with Mitsubishi Electric Corporation to deliver next-generation satellite...
WorthyTime Holdings Pte Ltd Announces Launch in Singapore's Luxury Watch Market
Newly formed luxury watch company brings together three businesses and their complementary expertise, with plans to build a leading office-based watch dealership in Singapore and Asia SINGAPORE, Sept. 11, 2026 /PRNewswire/ -- WorthyTime Holdings Pte...
THE GALIEN FOUNDATION ANNOUNCES INAUGURAL PRIX GALIEN JAPAN FORUM & AWARDS CEREMONY
Prestigious Life Sciences Platform and Awards Launch in Tokyo to Celebrate Breakthrough Innovation TOKYO, Sept. 11, 2026 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today...
Starlight Investments Announces Successful Close of UK BTR Fund II
Total capital commitments of £680 million across Fund II and ancillary investment vehicles will support the acquisition and delivery of over 6,000 homes – as Starlight continues to strengthen its position among the UK's largest BTR operators...